Report Overview

Global Nerve Repair and Regeneration Market- Industry Trends & Forecast Report 2027

The global nerve repair and regeneration market was worth USD 6.2 billion in 2020 and is further projected to reach USD 10.7 billion by the year 2027, growing at the CAGR of 7.6% in the forecast period. The market growth is influenced by factors such as the increasing prevalence of neurological disorders like Alzheimer’s, brain tumors, cerebral aneurysm, etc., along with the development and availability of treatment for such disorders in medical science. Furthermore, the availability of technologically advanced devices is also propelling the growth of the global nerve repair and regeneration market.

Source: BlueWeave Consulting

Global Nerve Repair and Regeneration Market- Overview

Nerve repair and regeneration is a procedure where the damaged nervous tissues, cells, or cell products are repaired or regrown. The surgical procedure of repair and regeneration involves the examination of the damaged nerve, then cutting and removing the injured tissue from the nerve ending. After this step, the nerve is directly reconnected with the other nerves which further allows the regeneration or healing without any obstacle. However, the procedure where the nerves or tissues are severely bruised or traumatized may take longer than usual.

Global Nerve Repair and Regeneration Market Forecast and Trends

Growth Drivers

Increasing Cases of Nervous System Injuries

The cases of nervous system injuries are increasing every year at a very rapid rate. Most of these cases are the result of road accidents, stretching or crushing trauma and fractures, burns, or gunshot wounds. As the prevalence of neurological injuries is rising, medical science is working hard towards developing effective treatment procedures for treating nerve injuries and recovering their functionality. This is being a major factor for the growth of the global nerve repair and regeneration market.

Rise in Healthcare Expenditure and Growing Awareness Neurological Disorders

With the increasing prevalence of various neurological disorders like epilepsy, seizures, Bell's palsy, Alzheimer’s disease, acute spinal cord injury, brain tumors, cerebral aneurysm, etc., people are educating themselves more and more towards the causes and cases of neurological disorders. This has made the diagnosis of such disorders at earlier stages easy as people are aware of the potential symptoms. Furthermore, the increasing healthcare expenditure has also propelled the demand for neurological surgical procedures, due to which the nerve repair and regeneration products and devices are gaining significant traction.

Restraints

High Complications involved in the Nerve Regeneration Procedure

Nerve repair and regeneration procedure is one of the most complicated procedures in medical science. Although the surgical procedures for peripheral nerve injuries are capable of self-healing to great extent, the risk of complications is still very high even after the application of the best micro-surgical technique. Due to the nonavailability of solutions for tackling motor or sensory abilities issues, the nerve repair and regeneration market is witnessing restrictive growth.

Impact of COVID-19 on Global Nerve Repair and Regeneration Market

The COVID-19 has affected the surgical sector in the healthcare industry very negatively. Several neurological surgical procedures were postponed for ensuring the safety of the patients and surgeons as well as to provide resources to deal with COVID-19 cases first. This subsequently declined the demand for nerve repair and regeneration devices. Furthermore, the market was also impeded as the imports and exports were temporarily halted, which affected the manufacturing and supply of such devices to the hospitals. However, in the post-COVID-19 period, the market is estimated to witness greater demand as all the neurological surgery processes resume.

Global Nerve Repair and Regeneration Market - By Product

The global nerve repair and regeneration market has prominent demand for neurostimulation and neuromodulation devices. It is further classified into internal neurostimulation and neuromodulation devices, external neurostimulation and neuromodulation devices, and biomaterials. Neurostimulators are devices that are used for delivering mild electrical signals near the spine through one or more thin wires. They are essentially used for altering pain signals which go to the brain. The availability of a large range of spinal cord products and devices plays a major factor in the growth of the Neurostimulation segment.

Global Nerve Repair and Regeneration Market - By Application

Based on applications, the global nerve repair and regeneration market is segmented into neurostimulation & neuromodulation applications and nerve repair & regeneration biomaterials. The neurostimulation and neuromodulation applications segment accounted for the largest market share. This segment is further divided into internal neurostimulation & neuromodulation and external neurostimulation & neuromodulation. Biomaterials are, however, gaining significant traction owing to approvals from clinical trials and the consistent developments taking place in this segment.

Global Nerve Repair and Regeneration Market - Regional Insights

Geographically, the global nerve repair and regeneration market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America dominates the market due to the high and increasing prevalence of neurological diseases. With developed healthcare infrastructure, the diagnosis and treatment of such neurological disorders are much more prominent in this region which is pulling the demand for nerve repair and regeneration devices in the region. Furthermore, the high concentration of leading market players in this region also plays a favorable factor for the market growth.

Competitive Landscape

The leading players in the global nerve repair and regeneration market are Stryker, Neuropace Inc., Livanova, Boston Scientific Corporation, Axogen Corporation, Neuronetics, Medtronic, Integra Lifesciences Corporation, Baxter, Abbott Laboratories, Polyganics, St. Jude Medical, Cyberonics, Inc, Soterix Medical, Inc., Nevro, Kerimedical, Biowave Corporation, Neuronetics, Inc., Synapse Biomedical, Inc., and other prominent players.

The market is highly consolidated and competitive with the presence of global players like Abbott Laboratories, and Boston Scientific Corporation, etc. dominating the market. The industry participants also invest in extensive research and development and focus on innovating and advancing products and technologies to grab a larger share in the market.

Recent Development

• In June 2021, Orthocell Ltd. announced to have received New Zealand and Chinese patents for its CelGro collagen medical device platform for soft tissue regeneration applications. Through this, Orthocell aims to strengthen its intellectual property position.
• In May 2021, CCRM, a fertility science, research, and advancement leader announced its partnership with leading Canadian and international institutions such as McGill University, McMaster University, Australia’s Monash University, and Starfish Innovations, a subsidiary of Leiden University Medical Center in the Netherlands, among others, to advance regenerative medicine inventions.

Scope of the Report

By Product

• Neurostimulation And Neuromodulation Devices
• Internal Neurostimulation And Neuromodulation Devices
• External Neurostimulation And Neuromodulation Devices
• Biomaterials

By Application

• Neurostimulation & Neuromodulation Applications
• Internal Neurostimulation & Neuromodulation
• External Neurostimulation & Neuromodulation
• Nerve Repair & Regeneration Biomaterials
• Direct Nerve Repair/Neurorrhaphy
• Nerve Grafting
• Stem Cell Therapy

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Latin America (LATAM)
• Middle-East & Africa (MEA)

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Research Methodology
   1. Qualitative Research
      1. Primary and Secondary Sources
   2. Quantitative Research
      1. Primary and Secondary Sources
   3. Breakdown of Primary Research Respondents
      1. Secondary Research
      2. Primary Research
   4. Breakdown of Primary Research Respondents, By Industry Participants
   5. Key Questionnaire asked during Primary Interviews
   6. Key Primary Responses
   7. Market Size Estimation
   8. Assumption for the Study
   9. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Nerve Repair and Regeneration Market – Industry Insights
   1. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
   2. Recent Developments / Technical Landscape
   3. Regulatory Framework
   4. Porter’s Five Forces Analysis
   5. Value Chain Analysis
   6. Strategic Outlook
5. Global Nerve Repair and Regeneration Market Overview
   1. Market Estimates & Forecast by Value, 2017-2027
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Product
         1. Neurostimulation And Neuromodulation Devices
            1. Internal Neurostimulation And Neuromodulation Devices
            2. External Neurostimulation And Neuromodulation Devices
            3. Biomaterials
      2. By Application
         1. Neurostimulation & Neuromodulation Applications
            1. Internal Neurostimulation & Neuromodulation
            2. External Neurostimulation & Neuromodulation
         2. Nerve Repair & Regeneration Biomaterials
            1. Direct Nerve Repair/Neurorrhaphy
            2. Nerve Grafting
            3. Stem Cell Therapy
      3. By Region
         1. North America
         2. Europe
         3. Asia-Pacific (APAC)
         4. Latin America (LATAM)
         5. Middle-East & Africa (MEA)
6. North America Nerve Repair andRegeneration Market Overview
   1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
         1. U.S.
         2. Canada
7. Europe Nerve Repair and Regeneration Market Overview
   1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
         1. Germany
         2. U.K.
         3. France
         4. Italy
         5. Spain
         6. Russia
         7. Netherlands
         8. Rest of Europe
8. APAC Nerve Repair and Regeneration Market Overview
   1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of APAC
9. LATAM Nerve Repair and Regeneration Market Overview
   1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
         1. Mexico
         2. Brazil
         3. Rest of LATAM
10. MEA Nerve Repair and Regeneration Market Overview
    1. Market Size and Forecast
       1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
       1. By Product
       2. By Application
       3. By Country
          1. Saudi Arabia
          2. UAE
          3. South Africa
          4. Turkey
          5. Rest of Europe
11. Competitive Landscape
    1. 1. List of Key Players and Their Offerings
       2. Market Share / Ranking Analysis (2020)
       3. Competitive Benchmarking, By Operating Parameters
12. COVID-19 Impact
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Stryker
    2. Neuropace Inc.
    3. Livanova
    4. Boston Scientific Corporation
    5. Axogen Corporation
    6. Neuronetics
    7. Medtronic
    8. Integra Lifesciences Corporation
    9. Baxter
    10. Abbott Laboratories
    11. Polyganics
    12. St. Jude Medical
    13. Cyberonics, Inc
    14. Soterix Medical, Inc.
    15. Nevro
    16. Kerimedical
    17. Biowave Corporation
    18. Neuronetics, Inc.
    19. Synapse Biomedical, Inc.
    20. Other Prominent Players
14. Key Strategic Recommendations

*Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

List of Figures

Fig1: Global Nerve Repair and Regeneration Segmentation

Fig 2: Global Nerve Repair and Regeneration Value Chain Analysis,

Fig 3: Company Market Share Analysis, 2020

Fig 4: Global Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 5: Global Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 6: Global Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 7: Global Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

Fig 8: North America Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 9: North America Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 10: North America Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 11: North America Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

Fig 12: Europe Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 13: Europe Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 14: Europe Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 15: Europe Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

Fig 16: the Asia-Pacific Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 17: the Asia-Pacific Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 18: the Asia-Pacific Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 19: Asia-Pacific Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

Fig 20: Latin America Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 21: Latin America Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 22: Latin America Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 23: Latin America Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

Fig 24: Middle East & Africa Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

Fig 25: Middle East & Africa Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

Fig 26: Middle East & Africa Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

Fig 27: Middle East & Africa Nerve Repair and Regeneration Share (%), By Region, By Value, 2017-2027

List of Tables

Table 1: Global Nerve Repair and Regeneration Size, By Product, By Value, 2017-2027

Table 2: Global Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 3: Global Nerve Repair and Regeneration Size, By Region, By Value (USD Billion), 2017-2027

Table 4: North America Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

Table 5: North America Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 6: North America Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

Table 7: Europe Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

Table 8: Europe Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 9: Europe Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

Table 10: the Asia-Pacific Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

Table 11: the Asia-Pacific Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 12: the Asia-Pacific Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

Table 13: Latin America Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

Table 14: Latin America Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 15: Latin America Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

Table 16: The Middle-East & Africa Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

Table 17: The Middle-East & Africa Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

Table 18: The Middle-East & Africa Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

Table 19: Stryker Financial Analysis

Table 20: Stryker Business Overview

Table 21: Neuropace Inc. Financial Analysis

Table 22: Neuropace Inc. Business Overview

Table 23: Livanova Analysis

Table 24: Livanova Overview

Table 25: Boston Scientific Corporation Analysis

Table 26: Boston Scientific Corporation Overview

Table 27: Axogen Corporation Financial Analysis

Table 28: Axogen Corporation Business Overview

Table 29: Neuronetics Financial Analysis

Table 30: Neuronetics Business Overview

Table 31: Medtronic Financial Analysis

Table 32: Medtronic Business Overview

Table 33: Integra Lifesciences Corporation Financial Analysis

Table 34: Integra Lifesciences Corporation Business Overview

Table 35: Baxter Financial Analysis

Table 36: Baxter Business Overview

Table 37: Abbott Laboratories Financial Analysis

Table 38: Abbott Laboratories Business Overview

Table 39: Polyganics Financial Analysis

Table 40: Polyganics Financial Analysis

Table 41: St. Jude MedicalFinancial Analysis

Table 42: St. Jude MedicalBusiness Overview

Table 43: Cyberonics, IncFinancial Analysis

Table 44: Cyberonics, IncBusiness Overview

Table 45: Soterix Medical, Inc.Financial Analysis

Table 46: Soterix Medical, Inc.Business Overview

Table 47: NevroFinancial Analysis

Table 48: NevroBusiness Overview

Table 49: KerimedicalFinancial Analysis

Table 50: KerimedicalBusiness Overview

Table 51: Biowave CorporationFinancial Analysis

Table 52: Biowave CorporationBusiness Overview

Table 53: Neuronetics, Inc.Financial Analysis

Table 54: Neuronetics, Inc.Business Overview

Table 55: Synapse Biomedical, Inc.Financial Analysis

Table 56: Synapse Biomedical, Inc.Business Overview